Track topics on Twitter Track topics that are important to you
Building 227 Porton Down Science Park
Phone: 44 (0)1980 551320
Fax: 44 (0)1980 551321
Biopharmaceutical firm Axovant Sciences has agreed exclusive worldwide rights for the development and commercialisation of gene therapy company Oxford BioMedica’s...Read More... The post Axovant buy...
Fintan Walton talks to Nick Woolf, Senior Vice President, Corporate Strategy, Oxford BioMedica, about the company’s ongoing success as it moves toward its ultimate goal of becoming a fully integrate...
Securing Oxford BioMedica's participation is indicative of the manufacturing hurdles present in gene therapy, particularly involving lentiviral vectors.
Oxford Biomedica intends to raise approximately £20.5m by way of a conditional placing of ordinary shares to raise money for expansion of bioprocessing facilities, the company said on Friday. The p.....
Axovant Sciences has signed an exclusive worldwide licensing agreement with Oxford BioMedica to develop and commercialise, OXB-10, to treat Parkinson’s disease.
Edison Investment Research - Pharmaceutical & healthcare - Oxford BioMedica: Oxford BioMedica (OXB) has signed an out-licensing deal with Axovant for its Parkinson’s disease (PD) gene therapy AX...
Edison Investment Research - Pharmaceutical & healthcare - Oxford BioMedica: Following the commercial launch in 2017 of partner Novartis’s CAR-T Kymriah (in r/r paediatric ALL), Oxford BioMedica...
Gene and cell therapy group Oxford BioMedica has entered into an exclusive worldwide licensing agreement with Nasdaq-listed Axovant Sciences that will see the pair develop and commercialise OXB-102...
Microcephaly is characterized by a smaller than normal head circumference. Recently, Zika virus (ZV) has been associated with microcephaly.
Acolyte Biomedica Ltd provides rapid diagnostic systems for clinical microbiology. Acolyte's BacLite® platform allows microbial detection in hours instead of days, improving laboratory workflow, redu...
Oxford BioMedica advanced gene therapy techniques.
Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral He...
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the...
The aCOLyte colony counter is available with two levels of functionality, Click’n’Count and SuperCount. Click'n'Count allows you to simply point to each colony and click to count. Click'n'Count ...
We have published hundreds of Acolyte Biomedica Ltd news stories on BioPortfolio along with dozens of Acolyte Biomedica Ltd Clinical Trials and PubMed Articles about Acolyte Biomedica Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acolyte Biomedica Ltd Companies in our database. You can also find out about relevant Acolyte Biomedica Ltd Drugs and Medications on this site too.
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...